 SHANGHAI, China, July 16, 2021 GLOBE NEWSWIRE -- ECMOHO Limited Nasdaq: MOHO ECMOHO or the Company, a leading integrated solutions provider in the health and wellness market in China, is pleased today to announce a strategic cooperation agreement with well-known South Korean pharmaceutical company, ChongKunDang Group hereafter referred to as CKD, in providing global marketing and multichannel sales for one-stop retail solutions for CKDs health products in China. With advanced equipment and cutting-edge technology as its foundation, CKD will be able to provide Chinese consumers with high-quality, diversified healthcare products, including probiotics, via ECMOHOs established and extensive domestic distribution channels. 